Heterogeneity in gene loci associated with type 2 diabetes on human chromosome 20q13.1

Genomics

Volumn 92, Issue 4, 2008, Pages 226-234

  Bento, J L ^a   Palmer, N D ^a   Zhong, M ^a   Roh, B ^a   Lewis, J P ^a   Wing, M R ^a   Pandya, H ^a   Freedman, B I ^a   Langefeld, C D ^a   Rich, S S ^b   Bowden, D W ^a   Mychaleckyj, J C ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Association; Chromosome 20; End stage renal disease; Haplotypes; Heterogeneity; Linkage disequilibrium; SNPs; Type 2 diabetes

Indexed keywords

CADHERIN; CADHERIN LIKE 22; CARRIER PROTEIN; DICARBOXYLATE TRANSPORTER; ENGULFMENT AND CELL MOTILITY 2 PROTEIN; HEPATOCYTE NUCLEAR FACTOR 4; PHOSPHATIDYLINOSITOL 3,4,5 TRIPHOSPHATE-DEPENDENT RAC EXCHANGER 1 PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; POTASSIUM CHLORIDE COTRANSPORTER; POTASSIUM CHLORIDE COTRANSPORTER MEMBER 5; SLC12A5 PROTEIN; SODIUM DEPENDENT DICARBOXYLATE TRANSPORTER MEMBER 3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CAUCASIAN; CELL MOTILITY; CHROMOSOME 20Q; CONTROLLED STUDY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CADHERINS; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 20; CYTOSKELETAL PROTEINS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; KIDNEY FAILURE, CHRONIC; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI;

EID: 51649090840     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2008.06.004     Document Type: Article

References (48)

1. Bowden D.W., et al. Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes 46 (1997) 882-886
2. Fossey S.C., et al. A high-resolution 6.0-megabase transcript map of the type 2 diabetes susceptibility region on human chromosome 20. Genomics 76 (2001) 45-57
3. Price J.A., et al. A physical map of the 20q12-q13.1 region associated with type 2 diabetes. Genomics 62 (1999) 208-215
4. Bagwell A.M., Bailly A., Mychaleckyj J.C., Freedman B.I., and Bowden D.W. Comparative genomic analysis of the HNF-4alpha transcription factor gene. Mol. Genet. Metab. 81 (2004) 112-121
5. Dawson P.A., et al. Sequence and functional analysis of GLUT10: a glucose transporter in the type 2 diabetes-linked region of chromosome 20q12-13.1. Mol. Genet. Metab. 74 (2001) 186-199
6. Bento J.L., et al. Genetic analysis of the GLUT10 glucose transporter (SLC2A10) polymorphisms in Caucasian American type 2 diabetes. BMC Med. Genet. 6 (2005) 42
7. Love-Gregory L.D., et al. A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4 alpha gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an Ashkenazi Jewish population. Diabetes 53 (2004) 1134-1140
8. Silander K., et al. Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes. Diabetes 53 (2004) 1141-1149
9. Bagwell A.M., et al. Genetic analysis of HNF4A polymorphisms in Caucasian-American type 2 diabetes. Diabetes 54 (2005) 1185-1190
10. Bento J.L., et al. Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes. Diabetes 53 (2004) 3007-3012
11. Palmer N.D., et al. Association of protein tyrosine phosphatase 1B gene polymorphisms with measures of glucose homeostasis in Hispanic Americans: the insulin resistance atherosclerosis study (IRAS) family study. Diabetes 53 (2004) 3013-3019
12. Takeuchi F., et al. Search of type 2 diabetes susceptibility gene on chromosome 20q. Biochem. Biophys. Res. Commun. 357 (2007) 1100-1106
13. Sandhu M.S., et al. Common variants in WFS1 confer risk of type 2 diabetes. Nat. Genet. 39 (2007) 951-953
14. Daly M.J., Rioux J.D., Schaffner S.F., Hudson T.J., and Lander E.S. High-resolution haplotype structure in the human genome. Nat. Genet. 29 (2001) 229-232
15. Gabriel S.B., et al. The structure of haplotype blocks in the human genome. Science 296 (2002) 2225-2229
16. Chumakov I., et al. Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia. Proc. Natl. Acad. Sci. USA 99 (2002) 13675-13680
17. Hugot J.P., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
18. Rioux J.D., et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat. Genet. 29 (2001) 223-228
19. Ghosh S., et al. Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc. Natl. Acad. Sci. USA 96 (1999) 2198-2203
20. Ji L., et al. New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes 46 (1997) 876-881
21. Zeggini E., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316 (2007) 1336-1341
22. Schaid D.J., Rowland C.M., Tines D.E., Jacobson R.M., and Poland G.A. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet. 70 (2002) 425-434
23. Freidlin B., Zheng G., Li Z., and Gastwirth J.L. Trend tests for case-control studies of genetic markers: power, sample size and robustness. Hum. Hered. 53 (2002) 146-152
24. Sasieni P.D. From genotypes to genes: doubling the sample size. Biometrics 53 (1997) 1253-1261
25. Slager S.L., and Schaid D.J. Case-control studies of genetic markers: power and sample size approximations for Armitage's test for trend. Hum. Hered. 52 (2001) 149-153
26. Zheng G. Use of max and min scores for trend tests for association when the genetic model is unknown. Stat. Med. 22 (2003) 2657-2666
27. Weiner O.D. Rac activation: P-Rex1-a convergence point for PIP(3) and Gbetagamma?. Curr. Biol. 12 (2002) R429-R431
28. Eichler E.E. Recent duplication, domain accretion and the dynamic mutation of the human genome. Trends Genet. 17 (2001) 661-669
29. Sugimoto K., et al. Molecular cloning and characterization of a newly identified member of the cadherin family, PB-cadherin. J. Biol. Chem. 271 (1996) 11548-11556
30. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-678
31. Saxena R., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316 (2007) 1331-1336
32. Sallinen R., et al. Chromosomal localization of SLC12A5/Slc12a5, the human and mouse genes for the neuron-specific K(+)-Cl(-) cotransporter (KCC2) defines a new region of conserved homology. Cytogenet. Cell Genet. 94 (2001) 67-70
33. Sauve F., et al. CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant. Mol. Cell. Biol. 21 (2001) 343-353
34. Heine P.A., Taylor J.A., Iwamoto G.A., Lubahn D.B., and Cooke P.S. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc. Natl. Acad. Sci. USA 97 (2000) 12729-12734
35. Florez J.C., et al. A 100K genome-wide association scan for diabetes and related traits in the Framingham Heart Study: replication and integration with other genome-wide datasets. Diabetes 56 (2007) 3063-3074
36. Hanson R.L., et al. A search for variants associated with young-onset type 2 diabetes in American Indians in a 100K genotyping array. Diabetes 56 (2007) 3045-3052
37. Hayes M.G., et al. Identification of type 2 diabetes genes in Mexican Americans through genome-wide association studies. Diabetes 56 (2007) 3033-3044
38. Rampersaud E., et al. Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the Old Order Amish: evidence for replication from diabetes-related quantitative traits and from independent populations. Diabetes 56 (2007) 3053-3062
39. Sladek R., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445 (2007) 881-885
40. Grant S.F., et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 38 (2006) 320-323
41. Altshuler D., et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet. 26 (2000) 76-80
42. Bai X., et al. Identification of basolateral membrane targeting signal of human sodium-dependent dicarboxylate transporter 3. J. Cell. Physiol. 206 (2006) 821-830
43. Wagenknecht L.E., et al. Familial aggregation of coronary artery calcium in families with type 2 diabetes. Diabetes 50 (2001) 861-866
44. Enattah N.S., et al. Identification of a variant associated with adult-type hypolactasia. Nat. Genet. 30 (2002) 233-237
45. Beaulieu M., and Hong P. Multiplexing the homogeneous MassEXTEND assay. Application Note (2004)
46. Oeth P., et al. iPLEXÔ assay: increased plexing efficiency and flexibility for MassARRAY system through single base primer extension with mass-modified terminators. Application Note (2005)
47. Wigginton J.E., Cutler D.J., and Abecasis G.R. A note on exact tests of Hardy-Weinberg equilibrium. Am. J. Hum. Genet. 76 (2005) 887-893
48. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265